Angel Cooper

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

Krasimir Vasilev, Galina Reshedko, Remus Orăsan et al. · Journal of Antimicrobial Chemotherapy · 2008 · 101 citations · Full text

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin

Carlos Bergallo, Abel Jasovich, Osvaldo Teglia et al. · Diagnostic Microbiology and Infectious Disease · 2008 · 96 citations

Community-acquired Pneumonia, Antimicrobial Stewardship, Antibiotics +8

Safety and Efficacy of Intravenous Tigecycline in Subjects with Secondary Bacteremia: Pooled Results from 8 Phase III Clinical Trials

David Gardiner, Gary Dukart, Angel Cooper et al. · Clinical Infectious Diseases · 2009 · 93 citations

Phase 3 study comparing tigecycline and ertapenem in patients with diabetic foot infections with and without osteomyelitis

Laszlo Lauf, Zsófia Ozsvár, J Regöly-Mérei et al. · Diagnostic Microbiology and Infectious Disease · 2013 · 91 citations · Full text

In vitro activity of danofloxacin, tylosin and oxytetracycline against mycoplasmas of veterinary importance

Angel Cooper, J Fuller, M.K. Fuller et al. · Research in Veterinary Science · 1993 · 78 citations

Veterinary Pathology, Immunology, Veterinary Science +7